Colorectal cancer screening: tests, strategies and perspectives

Colorectal cancer screening: tests, strategies and perspectives

Screening has a central role in colorectal cancer (CRC) control. Different screening tests are effective in reducing CRC-specific mortality. Influence on cancer incidence depends on test sensitivity for premalignant lesions, ranging from almost no influence for guaiac-based fecal occult blood testin...

Full description

Bibliographic Details
Main Authors:	Fabrizio eStracci, Manuel eZorzi, Grazia eGrazzini
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-10-01
Series:	Frontiers in Public Health
Subjects:	screening colorectal cancer advanced adenoma guaiac-based fecal occult blood test fecal immunochemical test flexible sigmoidoscopy
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fpubh.2014.00210/full

Similar Items

Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015–2016
by: Aysha Almansoori, et al.
Published: (2021-08-01)

Factors influencing colorectal cancer screening decision-making among average-risk US adults
by: Xuan Zhu, et al.
Published: (2022-12-01)

Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population
by: Brenner H, et al.
Published: (2017-07-01)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
by: P. H. A. Wisse, et al.
Published: (2022-12-01)

Physician‐office vs home uptake of colorectal cancer screening using FOBT/FIT among screening‐eligible US adults
by: Onyema Greg Chido‐Amajuoyi, et al.
Published: (2019-12-01)

The Roadmap of Colorectal Cancer Screening
by: Enea Ferlizza, et al.
Published: (2021-03-01)

Reducing the need for colonoscopy with adjusted FIT and FOBT for stool weight and serum Hb levels
by: Niousha Ghomashi, et al.
Published: (2023-10-01)

Performance of the fecal immunochemical test for colorectal cancer and advanced neoplasia in individuals under age 50
by: Emily Heer, et al.
Published: (2023-04-01)

Effects of Fecal Occult Blood Immunoassay Screening for Colorectal Cancer—Experience from a Hospital in Central Taiwan
by: Pei-Yu Yang, et al.
Published: (2023-03-01)

Primary care provider perspectives on the role of community pharmacy in colorectal cancer screening: a qualitative study
by: Alison T. Brenner, et al.
Published: (2023-08-01)

Clinical practice guidelines: Recommendations for CRC screening in Argentinian population with average risk based on iFOBT
by: Julia Ismael, et al.
Published: (2022-05-01)

Variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort
by: Brenner H, et al.
Published: (2018-04-01)

Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial
by: Elizabeth A. O’Connor, et al.
Published: (2020-01-01)

Colorectal cancer, screening: achievements и opportunities
by: E. A. Polyanskaya, et al.
Published: (2018-12-01)

Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT)
by: Emilie C. H. Breekveldt, et al.
Published: (2023-02-01)

Factors for effective colorectal cancer screening
by: Davorin Dajčman
Published: (2006-12-01)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
by: Efrat L. Amitay, et al.
Published: (2019-03-01)

Risk of colorectal cancer in patients with positive results of fecal immunochemical test performed within 5 years since the last colonoscopy
by: Yoon Suk Jung, et al.
Published: (2021-09-01)

Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial
by: Carrie M. Nielson, et al.
Published: (2018-09-01)

Polyprev: Randomized, Multicenter, Controlled Trial Comparing Fecal Immunochemical Test with Endoscopic Surveillance after Advanced Adenoma Resection in Colorectal Cancer Screening Programs: A Study Protocol
by: Cristina Regueiro, et al.
Published: (2021-08-01)

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
by: Yinan Ren, et al.
Published: (2022-08-01)

Implementing an Organized Colorectal Cancer Screening Program: Lessons Learned From an Academic–Community Practice
by: Amanda Kimura, MPH, et al.
Published: (2024-04-01)

Colorectal Cancer Screening Modalities in Chinese Population: Practice and Lessons in Pudong New Area of Shanghai, China
by: Wei-miao Wu, et al.
Published: (2019-06-01)

Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test
by: Xu-xia He, et al.
Published: (2019-12-01)

Diagnostic Performance of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program According to Ambient Temperature and Humidity
by: Gemma Ibáñez-Sanz, et al.
Published: (2022-02-01)

An Evolutionary Algorithm to Personalize Stool-Based Colorectal Cancer Screening
by: Luuk A. van Duuren, et al.
Published: (2022-01-01)

Diagnostic accuracy of risk assessment and fecal immunochemical test in colorectal cancer screening: Results from a population‐based program and meta‐analysis
by: Ziyang Wang, et al.
Published: (2023-09-01)

Evaluation of the Effectiveness of Colonoscopy, Fecal Immunochemical Test and Risk-adapted Screening Strategies in Population-based Colorectal Cancer Screening: A Multicenter Randomized Controlled Trial
by: CHEN Hongda, et al.
Published: (2023-01-01)

Which faecal blood test is more accurate in detecting bowel cancer and large polyps in population screening? (Russian Translation of Cochrane Plain Language Summary (PLS))
by: Kseniya S. Plyakhina
Published: (2022-11-01)

The Use of a Non-Invasive Biomarker for Colorectal Cancer Screening: A Comparative Cost-Effectiveness Modeling Study
by: Martin C. S. Wong, et al.
Published: (2023-01-01)

The advantages of the immunochemical test in detecting hidden blood in the stool
by: S. V. Vasiliev, et al.
Published: (2015-12-01)

Performance of the Fecal Immunochemical Test in Detecting Advanced Colorectal Neoplasms and Colorectal Cancers in People Aged 40–49 Years: A Systematic Review and Meta-Analysis
by: Jen-Hao Yeh, et al.
Published: (2023-05-01)

Effect of disease duration on fecal biomarkers in ulcerative colitis: a prospective cohort study
by: Natsuki Ishida, et al.
Published: (2022-09-01)

COLORECTAL CANCER SCREENING. CURRENT TECHNIQUES AND RECOMMENDATIONS REVIEW
by: D. P. Puzanov, et al.
Published: (2019-02-01)

COLORECTAL CANCER SCREENING. CURRENT TECHNIQUES AND RECOMMENDATIONS REVIEW
by: D. P. Puzanov, et al.
Published: (2019-02-01)

What do ‘false-positive’ stool tests really mean? Data from the New Hampshire colonoscopy registry
by: Lynn F. Butterly, et al.
Published: (2023-10-01)

Mailed fecal testing and patient navigation versus usual care to improve rates of colorectal cancer screening and follow-up colonoscopy in rural Medicaid enrollees: a cluster-randomized controlled trial
by: Gloria D. Coronado, et al.
Published: (2022-04-01)

Interval Cancer Rate and Diagnostic Performance of Fecal Immunochemical Test According to Family History of Colorectal Cancer
by: Yoon Suk Jung, et al.
Published: (2020-10-01)

Efficient organized colorectal cancer screening in Shenzhen: a microsimulation modelling study
by: Minmin Zhu, et al.
Published: (2024-03-01)

FIT-based risk-stratification model effectively screens colorectal neoplasia and early-onset colorectal cancer in Chinese population: a nationwide multicenter prospective study
by: Shengbing Zhao, et al.
Published: (2022-11-01)